BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

688 related articles for article (PubMed ID: 14720085)

  • 1. Antimalarial drug toxicity: a review.
    Taylor WR; White NJ
    Drug Saf; 2004; 27(1):25-61. PubMed ID: 14720085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antimalarial drug toxicity: a review.
    AlKadi HO
    Chemotherapy; 2007; 53(6):385-91. PubMed ID: 17934257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atovaquone + proguanil: new preparation. Second-line antimalarial combination.
    Prescrire Int; 2002 Oct; 11(61):131-6. PubMed ID: 12378742
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adverse effects of antimalarials. An update.
    Luzzi GA; Peto TE
    Drug Saf; 1993 Apr; 8(4):295-311. PubMed ID: 8481216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. UK malaria treatment guidelines.
    Lalloo DG; Shingadia D; Pasvol G; Chiodini PL; Whitty CJ; Beeching NJ; Hill DR; Warrell DA; Bannister BA;
    J Infect; 2007 Feb; 54(2):111-21. PubMed ID: 17215045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative efficacy and safety of chloroquine and alternative antimalarial drugs: a meta-analysis from six African countries.
    Mengesha T; Makonnen E
    East Afr Med J; 1999 Jun; 76(6):314-9. PubMed ID: 10750517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Atovaquone/proguanil: a review of its use for the prophylaxis of Plasmodium falciparum malaria.
    McKeage K; Scott L
    Drugs; 2003; 63(6):597-623. PubMed ID: 12656656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The proper use of antimalarial drugs currently available].
    Bourgeade A; Delmont J
    Bull Soc Pathol Exot; 1998; 91(5 Pt 1-2):493-6. PubMed ID: 10078393
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Artemisinin derivatives and malaria: useful, in combination with other antimalarials.
    Prescrire Int; 2008 Aug; 17(96):162-8. PubMed ID: 19492494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The safety of antimalarial drugs in pregnancy.
    Phillips-Howard PA; Wood D
    Drug Saf; 1996 Mar; 14(3):131-45. PubMed ID: 8934576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protective efficacy and safety of three antimalarial regimens for intermittent preventive treatment for malaria in infants: a randomised, double-blind, placebo-controlled trial.
    Gosling RD; Gesase S; Mosha JF; Carneiro I; Hashim R; Lemnge M; Mosha FW; Greenwood B; Chandramohan D
    Lancet; 2009 Oct; 374(9700):1521-32. PubMed ID: 19765815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and toxicity of sulfadoxine/pyrimethamine: implications for malaria prevention in pregnancy using intermittent preventive treatment.
    Peters PJ; Thigpen MC; Parise ME; Newman RD
    Drug Saf; 2007; 30(6):481-501. PubMed ID: 17536875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mefloquine. A review of its antimalarial activity, pharmacokinetic properties and therapeutic efficacy.
    Palmer KJ; Holliday SM; Brogden RN
    Drugs; 1993 Mar; 45(3):430-75. PubMed ID: 7682911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Malaria chemoprophylaxis regimens: a descriptive drug utilization study.
    Bloechliger M; Schlagenhauf P; Toovey S; Schnetzler G; Tatt I; Tomianovic D; Jick SS; Meier CR
    Travel Med Infect Dis; 2014; 12(6 Pt B):718-25. PubMed ID: 24934849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic responses to antimalarial and antibacterial drugs in vivax malaria.
    Pukrittayakamee S; Imwong M; Looareesuwan S; White NJ
    Acta Trop; 2004 Feb; 89(3):351-6. PubMed ID: 14744561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety, and tolerability of amodiaquine plus sulphadoxine-pyrimethamine used alone or in combination for malaria treatment in pregnancy: a randomised trial.
    Tagbor H; Bruce J; Browne E; Randal A; Greenwood B; Chandramohan D
    Lancet; 2006 Oct; 368(9544):1349-56. PubMed ID: 17046467
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant malaria in Bangui, Central African Republic: an in vitro assessment.
    Menard D; Djalle D; Manirakiza A; Yapou F; Siadoua V; Sana S; Matsika-Claquin MD; Nestor M; Talarmin A
    Am J Trop Med Hyg; 2005 Aug; 73(2):239-43. PubMed ID: 16103582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sulfadoxine-pyrimethamine, chlorproguanil-dapsone, or chloroquine for the treatment of Plasmodium vivax malaria in Afghanistan and Pakistan: a randomized controlled trial.
    Leslie T; Mayan MI; Hasan MA; Safi MH; Klinkenberg E; Whitty CJ; Rowland M
    JAMA; 2007 May; 297(20):2201-9. PubMed ID: 17519409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overview: clinical pharmacology of antimalarials.
    Karbwang J; Harinasuta T
    Southeast Asian J Trop Med Public Health; 1992 Sep; 23 Suppl 4():95-109. PubMed ID: 1364873
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 35.